Internal Medicine, Interventional Cardiology · Hammonton, NJ
NPI
1477532992
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2 Sindoni Ln
Hammonton, NJ, 08037
Phone (609) 561-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
3,032 services
Medicare patients, 2024
679
Average age 76
Drug cost, 2024
$1.6M
11,111 prescriptions
Company payments, 2025
$555
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerald Ukrainski was code 99214 (office e&m - established), 1,084 times for 506 patients. In total Gerald Ukrainski billed 3,032 services in 23 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,084 | 506 | $101.39 | $110K |
| 93000 Electrocardiogram | Office | 883 | 504 | $11.62 | $10K |
| 93306 Echocardiography (TTE/TEE) | Office | 283 | 275 | $97.38 | $28K |
| 93356 Echocardiography (TTE/TEE) | Office | 139 | 138 | $25.42 | $3,534 |
| 93248 Electrocardiogram | Office | 107 | 94 | $21.93 | $2,347 |
| 93246 Electrocardiogram | Office | 105 | 93 | $10.96 | $1,151 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 80 | 20 | $3.91 | $313 |
| 93016 Electrocardiogram | Office | 74 | 73 | $17.23 | $1,275 |
| 93018 Electrocardiogram | Office | 56 | 55 | $11.35 | $636 |
| 78452 Myocardial Perfusion Scan | Office | 55 | 54 | $87.68 | $4,822 |
| 99204 Office E&M - New | Office | 21 | 21 | $119.32 | $2,506 |
| 93244 Electrocardiogram | Office | 19 | 18 | $20.19 | $384 |
| 93242 Electrocardiogram | Office | 13 | 13 | $10.92 | $142 |
By year: 2022 $211K for 3,905 services; 2023 $185K for 3,411 services; 2024 $168K for 3,032 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gerald Ukrainski prescribed most often to Medicare patients was Rosuvastatin Calcium, with 969 prescriptions and refills. In total Gerald Ukrainski wrote 11,111 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 969 | 2,656 | 268 | $15K |
| Metoprolol Succinate Generic | 856 | 2,385 | 239 | $15K |
| Doxazosin Mesylate Generic | 726 | 2,043 | 205 | $13K |
| Atorvastatin Calcium Generic | 691 | 2,011 | 217 | $8,570 |
| Ezetimibe Generic | 542 | 1,465 | 153 | $18K |
| Eliquis Apixaban | 521 | 1,061 | 129 | $589K |
| Amlodipine Besylate Generic | 455 | 1,280 | 131 | $3,500 |
| Furosemide Generic | 370 | 1,029 | 112 | $2,299 |
| Hydralazine Hcl Generic | 360 | 980 | 98 | $4,240 |
| Metoprolol Tartrate Generic | 357 | 992 | 103 | $2,808 |
| Carvedilol Generic | 311 | 853 | 96 | $3,366 |
| Valsartan Generic | 274 | 780 | 77 | $8,610 |
| Torsemide Generic | 186 | 522 | 59 | $3,374 |
| Repatha Sureclick Evolocumab | 173 | 321 | 43 | $181K |
| Clopidogrel Clopidogrel Bisulfate | 166 | 451 | 51 | $2,861 |
Brand drugs: - claims; generic drugs: 9,618 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerald Ukrainski $555 ($555 in general payments such as food, travel and fees) from 12 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $129.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $129 |
| Abiomed JNJ | 1 | $90.86 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $48.52 |
| Impulse Dynamics (USA) Inc. | 2 | $45.65 |
| Boston Scientific Corporation BSX | 1 | $39.94 |
| Pfizer Inc. PFE | 2 | $37.67 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $36.95 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.21 |
| Esperion Therapeutics, Inc. ESPR | 2 | $27.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.